ITP
Clinical trials for ITP explained in plain language.
Never miss a new study
Get alerted when new ITP trials appear
Sign up with your email to follow new studies for ITP, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug hopes to raise platelet counts in teens with chronic bleeding disorder
Disease control Recruiting nowThis study tests an IV drug called efgartigimod in teens aged 12 to 18 who have had immune thrombocytopenia (ITP) for over a year. ITP causes low platelet counts, leading to bruising and bleeding. The goal is to find the right dose and see if it safely raises platelet levels. Par…
Matched conditions: ITP
Phase: PHASE2, PHASE3 • Sponsor: argenx • Aim: Disease control
Last updated May 26, 2026 12:09 UTC
-
New drug budoprutug aims to boost platelets in ITP patients
Disease control Recruiting nowThis study tests a new drug, budoprutug, in 24 adults with immune thrombocytopenia (ITP), a condition where the immune system destroys platelets, causing bleeding risks. The main goal is to check safety and find the right dose, while also seeing if it helps raise platelet counts.…
Matched conditions: ITP
Phase: PHASE1, PHASE2 • Sponsor: Climb Bio, Inc. • Aim: Disease control
Last updated May 22, 2026 13:51 UTC